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ABSTRACT
Objective The Latin American Network of Congenital 
Malformations: ReLAMC was established in 2017 to 
provide accurate congenital anomaly surveillance. This 
study used data from ReLAMC registries to quantify the 
prevalence of microcephaly from 2010 to 2017 (before, 
during and after the Zika virus epidemic).
Design Nine ReLAMC congenital anomaly registries 
provided case- level data or aggregate data for any live 
births, still births or terminations of pregnancy with 
microcephaly. Births to pregnant women infected with Zika 
virus first occurred in Brazil in 2015, and in the remaining 
registry areas in 2016 with the exception of Chile that 
did not experience Zika virus. Therefore the prevalence 
of microcephaly for 2010–2014 and individual years 
2015, 2016 and 2017 was estimated using multilevel 
random effect Poisson models. Clinical classification and 
characteristics of the cases were compared pre and post 
Zika for all centres providing individual case- level data.
Results The prevalence of microcephaly for all registries 
excluding Brazil was 2.3 per 10 000 (95% CI 2.0 to 2.6) for 
2010–2014 rising to 5.4 (95% CI 4.8 to 6.0) in 2016 and 
5.9 (95% CI 5.3 to 6.6) in 2017. Brazil had a prevalence of 
0.6 per 10 000 (95% CI 0.5 to 0.6) in 2010–2014, rising to 
5.8 (95% CI 5.6 to 6.1) in 2015, 8.0 (95% CI 7.6 to 8.3) in 
2016 and then falling in 2017. Only 29 out of 687 cases of 
microcephaly were reported as congenital Zika syndrome 
in countries excluding Brazil.
Conclusions The prevalence of microcephaly was 
influenced both by Zika causing congenital Zika syndrome 
and by increased reporting awareness.
INTRODUCTION
In late 2015, there were reports of a dramatic 
increase in the prevalence of microcephaly 
in babies born in Brazil coinciding with an 
outbreak of the Zika virus several months 
earlier.1 There is now sufficient evidence 
to confirm that Zika virus infection during 
the first trimester of pregnancy increases 
the risk of microcephaly in the baby.2 The 
microcephaly epidemic across Latin America 
highlighted the necessity of accurate congen-
ital anomaly surveillance. The Latin Amer-
ican Centre for Perinatology, Women and 
Reproductive Health of the Pan American 
Health Organization (PAHO/WHO) seeks to 
strengthen surveillance systems in the coun-
tries of the region.3 ReLAMC—the Latin 
American Network of Congenital Anomaly 
Surveillance was established in November 
2017 (https:// globalbirthdefects. tghn. org/ 
news/ new- surveillance- network- latin- amer 
icar elam cbui lding- strength/). The objectives 
of ReLAMC are to provide essential epidemi-
ologic information on congenital anomalies 
in Latin America and to improve detection of 
new epidemics of congenital anomalies.
This study aimed to use data from regis-
tries collaborating with ReLAMC to provide 
contemporary estimates of the prevalence of 
microcephaly across Latin America from 2010 
to 2017 to demonstrate the value and strength 
What is known about the subject?
 ► Many maternal infections (including Zika virus) in-
crease the risk of specific congenital anomalies 
occurring. The prevalence of microcephaly was re-
ported to increase in several areas with high levels 
of Zika virus infections.
What this study adds?
 ► The prevalence of microcephaly did increase in 
areas with Zika virus infections. However, some of 
these increases were due to the improved diagno-
sis or increased reporting of microcephaly that oc-
curred. Reporting of Zika virus and other maternal 
infections associated with the microcephaly was 
deficient.
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of ReLAMC. The prevalence of microcephaly was chosen, 
due to its association with the Zika virus epidemic and the 
associated interest in changes in its prevalence over the 
time of the epidemic observed in other studies4–12 and 
the lack of accurate information due to underreporting 
in the PAHO/WHO Zika virus surveillance system.13 In 
addition to the Zika virus, the STORCH infections ((s)
yphilis, (t)oxoplasmosis, (o)ther agents, (r)ubella, (c)
ytomegalovirus and (h)erpes simplex infection) are asso-
ciated with microcephaly in the fetuses and therefore 
information about STORCH infections is also important 
to report.
METHODS
Fifteen national and regional congenital anomaly regis-
tries in Latin America who are members of ReLAMC, 
or who are interested in participating in ReLAMC, 
were invited to take part in the study. Each registry 
completed a questionnaire concerning information on 
data availability on the coding and definition of micro-
cephaly, congenital Zika virus syndrome (CZS) and other 
maternal infections (STORCH) associated with micro-
cephaly. Only eight registries were able to contribute 
individual case data to this study. All information shared 
was previously anonymised. Each registry was required to 
obtain the necessary permissions to share the data with St 
George’s, University of London and several registries did 
not have the resources to obtain the necessary permis-
sion or to provide the data requested. Registries that were 
able to, provided anonymised case- level data for any live 
births, still births or terminations of pregnancy with a 
mention of microcephaly. Data on gender, birth weight, 
gestational age, head circumference and other additional 
anomalies were provided. If the registries were not able 
to provide individual case data, aggregate data were sent. 
Data on all birth outcomes from 1 January 2010 to 31 
December 2017 were sent including the total numbers of 
births for the area covered by the registry. For registries 
which sent individual case data, cases were classified clin-
ically by a paediatrician using international classification 
of diseases 10th revision (ICD- 10) codes only. Orioli et 
al14 did not include microcephaly associated with typical 
anencephaly or spina bifida. In this study, it is included.
Patient and public involvement
The public were not involved in the design, or conduct, 
or reporting, or dissemination plans of our research.
Statistical methods
Births to pregnant women infected with Zika virus first 
occurred in Brazil in 2015,9 10 15 and in the remaining 
registry areas in 20166 7 11 12 with the exception of Chile that 
did not experience Zika virus.11 The year of birth was there-
fore categorised into 2010–2014 (pre Zika for all regis-
tries), 2015 (Zika in Brazil only), 2016 (Zika in Brazil and 
all registries excluding Chile) and 2017. The prevalence of 
microcephaly was estimated using multilevel random effect 
Poisson models (Stata gllamm) nested within registry, with 
the number of cases as the dependent variable and the 
number of pregnancies as the exposure variable. Year of 
birth was considered as a random effect with indicator vari-
ables identifying the individual years 2015, 2016 and 2017. 
Models were fitted for all registries excluding Brazil. Brazil 
was considered separately due to the much larger numbers 
of births and the earlier timing of the Zika virus epidemic. 
Prevalence rate ratios (PRRs) for each of 2015–2017 relative 
to 2010–2014 were estimated. Multilevel models were used 
as they assume that the true prevalence will vary over time 
in each registry and also vary between registries. Poisson 
models were used as these models predict rare events 
(microcephaly case) in a population with many events (all 
births). Exact Poisson 95% CIs are provided. Clinical clas-
sification and characteristics of the cases for 2010–2015 
versus 2016–2017 (Brazil 2010–2014 vs 2015–2017) were 
compared using χ2 and Fisher’s exact tests. All analyses 
were carried out in Stata V.16.
RESULTS
Information from questionnaires
Questionnaire responses were provided from 12 regis-
tries: Argentina (National), Brazil (National), Chile 
(National), Chile (Maule), Colombia (Bogota), Colombia 
(Cali), Costa Rica (National), Mexico (Nuevo León), 
Nicaragua (León), Panama, Paraguay and Uruguay. 
Eight registries also provided individual anonymised 
case data and annual births populations for the area 
covered by their registry: Argentina (2010–2016), Brazil 
(National), Chile (National), Chile (Maule), Colombia 
(Bogota), Colombia (Cali), Costa Rica (National) and 
Mexico (Nuevo León). Nicaragua (León) provided 
prevalence rates only and Argentina provided aggregate 
data for 2017. Table 1 provides information on the nine 
registries providing data on microcephaly. There were 
three population- based registries and the size of their 
birth populations varied considerably, from 10 000 to 3 
million, reflecting whether they were regional or national 
registries.
Microcephaly
Table 1 shows how the registration of microcephaly cases 
varies according to the registry. All registries rely on clini-
cians diagnosing microcephaly—none of them rely solely 
on the head circumference measurement. However, 
there were variations in the national guidelines, with all 
guidelines defining microcephaly occurring when the 
head circumference is less than 2SD below the mean for 
age and sex, apart from Brazil whose guidelines changed 
from less than 3SD to less than 2SD in 2016. Seven regis-
tries routinely recorded head circumference when a 
diagnosis of microcephaly was reported, with Costa Rica 
starting to record head circumference in 2016.
Congenital Zika virus syndrome
The two registries in Colombia had a special reporting 
system for CZS while the other registries had introduced 
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CZS codes into their databases. Costa Rica also has a 
special surveillance subsystem for CZS, but data were not 
available at the time of this study.
Microcephaly associated with maternal infections other than Zika
There is screening for syphilis and HIV in 11 registries, 
for toxoplasmosis in 7, rubella in 5 and for Cytomegalo-
virus (CMV) in 2. However, only five registries (Argen-
tina, Brazil, Colombia Bogota, Colombia Cali and Nica-
ragua) reported that maternal infections were coded if 
the information was available, but stated that this infor-
mation was often incomplete. Three countries (Brazil, 
Chile and Costa Rica) have separate surveillance systems 
for maternal infections, but these are not directly linked 
through to the congenital anomaly registry.
Analysis of microcephaly case data
In tables 2–4, data for Brazil are presented separately due 
to the larger numbers of births and the earlier timing of 
the Zika virus epidemic, with the subsequent increases 
in microcephaly due to CZS expected to start in 2015 in 
Brazil and 2016/2017 in the other countries.
Figure 1 shows the prevalence of microcephaly cases 
for 2010–2014 for each registry and table 2 in addition 
compares the prevalence for each individual year from 
2015 to 2017 with that in 2010–2014. The overall preva-
lence of microcephaly for all centres excluding Brazil for 
2010–2014 was 2.3 per 10 000 (95% CI 2.0 to 2.6) rising 
to 5.4 (95% CI 4.8 to 6.0) in 2016 and 5.9 (95% CI 5.3 to 
6.6) in 2017. In contrast, Brazil had a prevalence of 0.6 
per 10 000 (95% CI 0.5 to 0.6) in 2010–2014, rising to 5.8 
(95% CI 5.6 to 6.1) in 2015, 8.0 (95% CI 7.6 to 8.3) in 2016 
and then falling in 2017, 1.9 (95% CI 1.8 to 2.1). There 
was variation between centres both in the prevalence 
rates and when the increases occurred. Chile (Maule) 
and the two Colombian centres had their highest rates 
in 2016, whereas other centres had their highest rates 
in 2017. Brazil experienced a 10- fold increase in preva-
lence in 2015 compared with 2010–2014, continuing to 
rise in 2016. As well as Brazil, Colombia (Bogota) had a 
significant increase in 2015 compared with 2010–2014. 
All centres experienced significant increases between 
2016 and 2017 relative to their 2010–2014 levels except 
for Argentina which showed little change.
Table 2 shows the 29 microcephaly cases that were iden-
tified as CZS cases in the registries compared with the 
much greater increases in microcephaly. The registries 
used different coding systems. In Argentina, one case was 
coded U06.9 ‘Zika virus disease, unspecified’, one coded 
‘A92.8’, ‘Other specified mosquito- borne viral fevers’ 
and there was a mention of Zika in a text field for the 
three other cases. In Costa Rica, the 20 cases had P35.8 or 
P35.82 ‘Other congenital viral diseases’ coded with Zika 
virus mentioned in the text descriptions and ‘A92.8: Zika’ 
also specified under maternal illness in six of their cases. 
In Mexico, the registry coded A92.9 ‘Mosquito- borne 
viral fever, unspecified’ under maternal illness during 
pregnancy with additional text confirming Zika virus and 
the Colombia, Cali registry had mention of confirmed 
Zika in the text field for maternal infections for one case. 
No information on whether the CZS cases had laboratory 
confirmation was recorded in any registry.
Table 3 compares the clinical classification of micro-
cephaly cases in the years before the Zika virus epidemic 
(2010–2015) with the years during and after the 
epidemic (2016–2017) for all countries except Brazil. 
For Brazil the Zika virus epidemic occurred earlier in 
2015 and therefore the years 2010–2014 are compared 
with 2015–2017. As expected the prevalence of isolated 
microcephaly increased with the occurrence of Zika with 
a greater proportion of all microcephaly cases being 
isolated. For all centres excluding Brazil, the prevalence 
of microcephaly with associated malformations of neural 




Coverage (hospital or 
population- based)*
Start of data 
collection




Argentina RENAC National, 40% of all births. (H) 2009 300 000 A+C
Brazil SINASC—SIM National. (P) 2000 3 000 000 A+B to 2016, 
then C
Chile RENACH National. (H) 2016 133 000 A+C
Chile—Maule RRMC- SSM Regional, Maule district, covers 
5.5% of Chile. (P)
2001 13 000 A+B
Colombia—Bogota CMSP Bogota DC. (H) 2006 110 000 A+C
Colombia—CALI CBDSP City of Cali. (H) 2011 35 000 A+C
Costa Rica CREC National system, all births. (P) 1987 70 000 A+C
Mexico—Nuevo 
Leon
ReDeCon HU- NUEVO 
LEÓN
Regional. (H) 2015 10 000 A+C
Nicaragua—Leon SVDC UNAN- LEÓN Regional, city of Leon. (H) 2005 10 000 A+C
*H: hospital- based; P: population- based.
†A: as clinically diagnosed, no national guidelines; B: guidelines for surveillance specify <−3SD; C: guidelines for surveillance specify 
<−2SD or third percentile.
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origin and with genetic syndromes (excluding chromo-
somal) did not significantly change, and polymalformed 
without syndrome diagnosis increased although the rela-
tive proportion decreased (due to the increase in isolated 
microcephaly). In Brazil, the prevalence of microcephaly 
increased in all classifications, although the relative 
proportions decreased (due to the increase in isolated 
microcephaly). The number of microcephaly cases asso-
ciated with maternal infections did increase in the later 
years, but was still extremely low.
Table 4 compares the characteristics of the micro-
cephaly cases in the years before the Zika virus epidemic 
(2010–2015) with the years during and after the epidemic 
(2016–2017) for all countries except Brazil. As in table 3, 
the data from Brazil are presented separately for 2010–
2014 compared with 2015–2017 to reflect the occurrence 
of the Zika virus epidemic in 2015 in Brazil compared 
to 2016/2017 in the other countries. For all centres 
cases excluding Brazil, the proportion of extremely low 
birthweights (<3 SD) remained similar; for Brazil, this 
proportion decreased after 2014. All centres reported 
statistically significantly smaller head circumferences 
(Brazil did not provide this data). However, they were less 
likely to be a pre- term or twin birth in the later years. It is 
also important to note that there were far more missing 
head circumferences in the earlier period in the table 
(2010–2015).
DISCUSSION
This is the second paper reporting results from the newly 
formed ReLAMC network.16 It provides additional data 
in the impact of Zika virus on the prevalence of micro-
cephaly in seven countries in Latin America. For most 
registries, there are clear increases in the prevalence of 
microcephaly in 2016 and 2017 compared with those 
born in 2010–2015 which are consistent with the reported 
dates for the Zika virus epidemics and first trimester tera-
togenicity.5–7 12 The Zika virus epidemic occurred earlier 
inBrazil4 8–10 and therefore the increase in microcephaly 
started in 2015. Those born in later years were also more 
likely to be isolated microcephaly cases.
A small number of the cases born from 2010 to 2014 
from Argentina, Chile and Colombia are included in 
the study by Orioli et all.14 This examined the preva-
lence of microcephaly in South America using data 
from ECLAMC (Latin American Collaborative Study of 
Congenital Malformations) which is derived from 107 
hospitals in 10 South American countries from 2005 to 
2014. The distribution of the clinical classification of the 
cases differed between the two studies, with the ReLAMC 
study having higher proportions ‘Isolated microcephaly 
cases’. This might be explained by this study classi-
fying the cases according to ICD- 10 codes, whereas the 
ECLAMC study had access to the written clinical descrip-
tions, image results and other clinical information.
Table 3 Clinical classification of microcephaly cases: comparing earlier years (pre- Zika) with later years (during and after 
Zika)









Birth years 2010–2015† 2016–2017‡ 2010–2014 2015–2017
Population births 2 339 898 1 161 854 14 564 103 8 799 003
Cases (%)
Prev. per 
10 000 Cases (%)
Prev. per 
10 000 Cases (%)
Prev. per 













10 (2) 0.04 13 (2) 0.11 p=0.025 Information not provided   








25 (5) 0.11 18 (3) 0.15 p=0.257 86 (10) 0.06 95 (2) 0.11 p<0.001
Isolated 
microcephaly
209 (38) 0.89 411 (60) 3.54 p<0.001 469 (55) 0.32 3907 (85) 4.44 p<0.001
Total microcephaly 543 (100) 2.32 687 (100) 5.91 p<0.001 852 (100) 0.58 4588 (100) 5.21 p<0.001
*Mexico Nuevo León contributed data for 2015–2017 only, Chile National for 2016–2017 only and Colombia Bogota for 2014–2017 only.
†Total microcephaly cases, 543, for 2010–2015 excludes 11 cases from Nicaragua as case- level data not available.
‡Total microcephaly cases, 687, for 2016–2017 excludes 30 cases from Nicaragua in 2016–2017 and 78 cases from Argentina in 2017 as case- level data not 
available for these years.
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Data from the PAHO/WHO publications of cumula-
tive cases of CZS available on the website (https://www. 
paho. org/ hq/ dmdocuments) up until January 2018 
indicate that, in the registries in this study, the highest 
prevalences of CZS occurred in Brazil and Colombia 
and slightly lower ones in Costa Rica, which would be 
confirmed by the large increases in prevalence observed 
in Brazil, Bogota and Cali and the increases in Costa 
Rica.7 However, Argentina reported five cases to PAHO/
WHO, which were identified in the data and they do not 
account for the increases in microcephaly observed in 
Argentina from 2015 to 2017, indicating these increases 
are likely due to be to improved diagnosis or more 
reporting of microcephaly. It is possible that other coun-
tries also observed an increase in prevalence of micro-
cephaly which was partly due to Zika, and partly due to 
increased reporting. No CZS cases were reported in Chile 
which is expected as there are no aedes mosquitos that 
Table 4 Characteristics of microcephaly cases





2010–2015† 2016–2017‡ 2010–2014 2015–2017
n (%) n (%) n (%) n (%)
All cases 543 (100) 687 (100) 852 (100) 4588 (100)
Birth outcome§ Live birth 523 (97) 661 (97) 0.72 852 (100) 4588 (100)
Stillbirth 17 (3) 19 (3) 0 0
Sex Male 226 (42) 299 (44) 0.73¶ 371 (45) 1853 (41) 0.04
Female 307 (57) 374 (55) 461 (55) 2702 (59)
Indeterminate 8 (1) 12 (2) 0 0
Twin Yes 19 (5) 13 (2) 0.009 29 (3) 85 (2) 0.017
Prenatally 
diagnosed
Yes 77 (19) 91 (17) 0.38 No information
Pre- term <37 weeks 179 (33) 190 (28) 0.032 213 (25) 870 (19) <0.001
Term not specified 17 (3) 15 (2) 235 (28) 99 (2)
Birth weight <2500 g 286 (54) 356 (59) 0.045 447 (52) 1881 (41) <0.001
Birth weight z- 
score
No information 25 (5) 92 (13) <0.001 237 (28) 103 (2) <0.001
<−3SD 31/518 (6) 31/595 (5) <0.001 53/615 (9) 167/4485 (4) <0.001
−3SD to <−2SD 69/518 (13) 111/595 (19) 71/615 (12) 597/4485 (13)
−2SD to <−1SD 145/518 (28) 207/595 (35) 159/615 (26) 1422/4485 (32)




No information 364 (67) 195 (28) <0.001     
<−3SD 45/179 (25) 152/492 (31)   
−3SD to <−2SD 66/179 (37) 220/492 (45) 0.01 No information
−2 SD to <−1SD 50/179 (28) 89/492 (18)
≥−1SD 18/179 (10) 31/492 (6)
Head 
circumference z 
score in pre- term 
births
<−3SD 13/39 (33) 50/134 (37)   
−3SD to <−2SD 9/39 (23) 57/134 (43) 0.005 No information
−2SD to <−1SD 11/39 (28) 11/134 (8)   
≥−1SD 6/39 (15) 16/134 (12)   
Head 
circumference 
z score in term 
births
<−3SD 32/140 (23) 102/358 (28)   
−3SD to <−2SD 57/140 (41) 163/358 (46) 0.08 No information
−2SD to <−1SD 39/140 (28) 78/358 (22)     
≥−1SD 12/140 (9) 15/358 (4)     
*Mexico Nuevo Leon contributed data for 2015–2017 only, Chile National for 2016–2017 only and Colombia Bogota for 2014–2017 only.
†Total microcephaly cases, 543, for 2010–2015 excludes 11 cases from Nicaragua as case- level data not available.
‡Total microcephaly cases, 687, for 2016–2017 excludes 30 cases from Nicaragua and 78 cases from Argentina (2017) as case- level 
data not available.
§Birth outcome: n=661 live births in 2016–2017 includes 121 cases from Chile National who do not collect data on still births. p=0.82 
for 2010–2015 versus 2016–2017 excluding these cases.
¶p=0.48 when the indeterminate sex is excluded.
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carry Zika virus in Chile and therefore the increases in 
the prevalence of microcephaly are likely to be due to 
increased reporting. The prevalence of microcephaly was 
extremely low in Brazil in 2010–2014, which is likely to be 
due to under- reporting in these years, with the change 
of definition of severe microcephaly exaggerating the 
differences in prevalence in the later years.
There were only 29 cases of Zika virus with microcephaly 
recorded in countries excluding Brazil, despite dramatic 
increases in the prevalence of microcephaly during this 
time. The increase in prevalence of microcephaly (partic-
ularly isolated) is likely to be due to both cases of CZS 
not being recorded and to a higher proportion of micro-
cephaly cases being reported due to the impact of the 
Zika virus epidemic and the associated increased risk of 
microcephaly raising awareness about reporting micro-
cephaly. All the registries, apart from Brazil, stated that 
the diagnostic criteria for microcephaly did not change 
during this time period. However, the Centers for Disease 
Control and Prevention (CDC) did develop a new case 
definition in 2016 for surveillance of birth defects poten-
tially related to Zika virus infection, which was shown to 
identify a greater number of cases with microcephaly 
when applied retrospectively to birth defects occurring 
in 2013/2014.17
A very small proportion of cases were reported as 
embryopathies due to maternal infections other than Zika 
virus, indicating that although there is increasing aware-
ness of microcephaly this awareness does not extend to 
the diagnosis and reporting of all maternal infections. 
The lack of accurate information on congenital infection 
syndromes shows the difficulties experienced in diag-
nosing and recording such cases in health systems and 
registries, as well as the lack of communication between 
maternal infection and congenital anomaly surveil-
lance systems. Coding of congenital infections is mainly 
outside the Q chapter of the ICD coding system devoted 
to congenital anomalies, and there is not a clear divi-
sion between maternal and fetal infection in the coding 
system. The burden of STORCH infections in Latin Amer-
ican countries is estimated to be considerable.18–21 As the 
prevalence of these maternal infections can be reduced 
by Public Health measures, this group of congenital 
anomalies is a preventable group for which it is valuable 
to have good estimates of baseline prevalence in order to 
encourage any actions that will reduce the prevalence, 
including screening (which is variable across countries) 
and the development of vaccines.
This paper shows that there is much work to be done 
in each of the countries to improve the reporting of 
congenital anomalies associated with maternal infec-
tions, including CZS, in order to evaluate preventive 
measures. It demonstrates the difficulties of interpreting 
microcephaly data, which was influenced both by Zika 
and by increasing reporting awareness. It also shows the 
power of data sharing in the Latin American region for 
congenital anomaly surveillance.
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